However, there are many barriers that must be overcome before widespread adoption including cost, reimbursement, data quality and lack of clinical evidence.
Preorders will begin on September 6th, with the aluminum version going for $280 for the 40mm size and $300 for the 44mm version.
The new feature brings push health nudges and personalized health insights to smartphone users with chronic conditions.
The combined solution will allow providers to access data remotely, gaining more insight into how patients are using the technology.
New capabilities include women cycle tracking, Noise app, Activity Trends and App Store right on the wrist; also, there are new watch faces.
While wrist-worn wearables accounted for the majority of the market with 63.2% share, ear-worn devices experienced the fastest growth (135.1% YoY).
The company is reportedly developing a wrist-worn device that would determine your emotions to make helpful suggestions and sell you products.
The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during Q2 2019.
Such technology would enable owners of future iPhones and Apple Watches to detect things like spoiled food, body odor and perhaps even blood sugar levels.
Also announced were six Alexa healthcare skills from leading healthcare providers, payors, pharmacy benefit managers and digital health coaching companies.